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Abstract
Background/Aims: The aim of this prospective study was to 
estimate gender differences in anxiety, depression, and alco-
hol use severity among patients with alcohol use disorder 
(AUD) before and after detoxification program and within 
12 months after discharge. Methods: AUD severity, state and 
trait anxiety, and depression were assessed in 187 patients 
entering an inpatient alcohol detoxification program. Fol-
low-up assessments were performed at 6 and 12 months af-
ter discharge. A between- and within-subjects analyses ex-
plored gender differences. The predictive value of anxiety 
and depression for alcohol relapse was analyzed by logistic 
and linear regression in both genders. Results: Females had 
higher levels of anxiety and depression than males both at 
admission and after discharge. Trait anxiety and depression 
significantly increased 6 months after discharge in males 
and females respectively. Both state and trait anxiety levels 
at the 6-month follow-up predicted alcohol relapse at the 
12-month follow-up in males. Conversely, in females, de-
pression level at the 6-month follow-up was a predictor of 
relapse at the 12-month follow-up. Conclusions: In both 
genders, the psychopathological dimension that showed 
the most significant worsening at 6-month follow-up (i.e., 
anxiety in males and depression in females) was found to be 
a significant predictor of relapse at the 12-month follow-up.
© 2018 The Author(s) 
Published by S. Karger AG, Basel
Introduction
Alcohol use disorder (AUD) is a maladaptive pattern 
of alcohol use, leading to clinically significant impair-
ment or distress [1]. In the last 20 years, epidemiological 
studies, such as the Epidemiologic Catchment Area and 
National Epidemiologic Survey on Alcohol and Related 
Conditions, have reported a high lifetime prevalence of 
psychiatric disorders among patients with AUD ranging 
from 38 to 39.5% [2, 3]. Anxiety and depressive disorders 
have been shown to be more prevalent in AUD patients 
in both epidemiological surveys [2–9] and clinical trials 
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[10–12]. Indeed, anxiety and depressive disorders are as-
sociated with a greater risk of relapse following alcohol 
detoxification (OR 4.4, 95% CI 1.8–10.1 for anxiety dis-
orders and OR 2.1, 95% CI 1.3–3.4 for depressive disor-
ders of relapse at 1 year) [13, 14]. 
Many important differences between males and fe-
males have emerged regarding alcohol drinking behav-
iors and patterns, related to both biological (sex-related) 
and psycho-socio-cultural (gender-related) factors [15]. 
Depressive symptoms appear to be implicated in the de-
velopment of AUD in women and to impact the frequen-
cy of high-risk drinking situations [16]. Gender differ-
ences in alcohol relapse have been correlated with differ-
ent mood states [17]. The association between gender 
differences in depressive symptoms and risk of relapse 
was assessed in a retrospective study, where the burden of 
symptoms in women was found to correlate with an in-
creased risk of relapse [18]. Moreover, females with AUD 
showed to be more prone to drink in negative emotional 
situations than males, although this does not seem to be 
related to the presence of depressive or anxiety disorders 
[19]. A recent prospective observational study focusing 
on gender differences during alcohol detoxification found 
a correlation between negative affect and craving, espe-
cially in women [20]. However, to the best of our knowl-
edge, there have been no prospective studies on gender 
differences in anxiety and depression levels before versus 
after alcohol detoxification. 
The aims of this study were to evaluate gender differ-
ences in trait and state anxiety and depression at admis-
sion, at discharge, and within 12 months following alco-
hol detoxification, and to determine whether levels of 
anxiety/depression could be used as gender-specific fac-
tors to predict the likelihood of relapse and the severity of 
alcohol use within 12 months after detoxification.
Methods
Sample and Enrolment 
A consecutive sample of patients admitted for inpatient alcohol 
detoxification treatment was recruited at the Hospital Complex 
“Fatebenefratelli” in San Maurizio Canavese (Turin, Italy) between 
September 1, 2013 and December 1, 2014. According to the hospi-
tal regulation, the admission is allowed to adult patients (at least 
18 years old) referred and diagnosed with Diagnostic and Statisti-
cal Manual of Mental Disorders, 4rd ed., text rev. DSM-IV-TR 
AUD (i.e., both alcohol abuse and alcohol dependence) by a ter-
ritorial addiction outpatient service (“Servizio per le dipendenze 
patologiche”) specialist (i.e., psychiatrist or MD trained in addic-
tive medicine), who must also exclude a diagnosis of any DSM-IV-
TR substance use disorder. Moreover, all patients were screened 
by urinalysis prior to admission to exclude substance use (i.e., Can-
nabis, Cocaine, Opiates, Amphetamines, Methamphetamines, 
Barbiturates, Benzodiazepines, Buprenorphine, Methadone). The 
inclusion and exclusion criteria for participating in the study were 
consistent with criteria applicable for those who were ready for 
hospital admission. 
The research protocol was not submitted to local Ethics Com-
mittee because, according to Italian Law, the approval was request-
ed only for experimental and observational studies on pharmaco-
logical treatments. Nevertheless, patients were provided with com-
prehensive information regarding the aims, methods, risks, and 
benefits of the study. All patients signing a written informed con-
sent form received a unique identification code in order to main-
tain data anonymity and patient confidentiality. All precautions 
were taken for the management of sensitive data, and participants 
were not given monetary compensation for their involvement.
Alcohol Detoxification Program
All patients admitted to the hospital stopped drinking alcohol. 
Detoxification treatment was based on a classical 1-week fixed-
schedule regimen [21, 22]. During hospitalization, other psycho-
pharmacological treatments were administered according to the 
evidence-based recommendations described in the American 
Psychiatric Association Practice Guidelines [23]. Several non-
pharmacological treatments, such as parent-training interven-
tion, short-term individual psychotherapy, group psychotherapy, 
motivational enhancement therapy, and nutrition education, 
were included at the discretion of the clinician. In accordance with 
the observational study design, the investigators were not actively 
engaged in providing treatment. All additional therapeutic inter-
ventions were recorded as dichotomous variables in the study da-
tabase.
Study Design
The longitudinal design of the observational study consisted of 
4 stages of observation and assessment: baseline assessment (T0); 
discharge assessment (T1); first follow-up at 6 months after dis-
charge (T2); and second follow-up at 12 months after discharge 
(T3). The T0 assessment was made on the seventh day of hospital-
ization and involved the collection of both sociodemographic in-
formation (date of birth, gender, marital status, education, living 
conditions, and employment) and alcohol intake-related data (age 
at onset of alcohol use, age at onset of alcohol abuse, previous 
admission(s) for detoxification, and current pharmacological 
treatment), and the administration of assessment tools. The sever-
ity of alcohol use was evaluated using the AUDs Identification Test 
(AUDIT) [24]. Baseline psychopathology was estimated using the 
State-Trait Anxiety Inventory – Form Y (STAI-Y) [25] and the 
Beck Depression Inventory (BDI) [26]. At discharge, only anxiety 
and depression were assessed using STAI-Y and BDI. All follow-
ups included the assessment of alcohol use severity, state/trait anx-
iety, and depression by AUDIT, STAI-Y, and BDI respectively. 
From the patient’s perspective, failure to sign the written informed 
consent form or to attend the follow-up appointments was consid-
ered refusal. In order to plan the follow-up controls, patients were 
asked to contact the hospital 1 week before follow-ups expiration 
dates by letter and e-mail, and they were also called by phone 
twice/week during 2 weeks after follow-ups expiration dates. Pa-
tients who could no longer be contacted at T1 and T2 were consid-
ered lost to follow-up.
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Assessment Tools
The AUDIT consists of a 10-item core questionnaire that ac-
cording to the manual should be administered after the clinical 
screening procedure is completed. Total score ranges from 0 to 40, 
is questionnaire-based only, and gives a reliable estimate of the se-
verity of alcohol use in the preceding year [27]. In addition to al-
cohol dependence, this tool explores the risk of alcohol intake-re-
lated physical/mental harm arising from hazardous or harmful 
drinking conduct. The international and Italian versions of this 
tool have both been verified for their good psychometric proper-
ties [28, 29]. In accordance with the AUDIT manual, 3 threshold 
values were used to identify 4 zones of risk and intervention. In the 
present study, patients with a score on the first item of 0 were con-
sidered abstinent; thus, all patients with scores above 0 on first item 
at follow-up were considered relapsed. Moreover, since the study 
design included a 6-month scheduled follow-up, the time refer-
ence of the questionnaire was reduced from 12 to 6 months. 
STAI-Y and BDI were used to achieve continuous measure-
ment of anxiety and depression symptoms respectively. The 
 STAI-Y inventory consists of 40 items and is specifically designed 
to assess both trait and state anxiety. STAI-Y has been proven to 
have good psychometric properties for assessing patients with 
AUD (internal reliability, α = 0.86–0.95) [25, 30]. The total score 
for each type of anxiety ranges from 20 to 80, with higher scores 
suggesting greater levels of anxiety. The STAI-Y has been trans-
lated and validated in its Italian version [31]. Similarly, the BDI 
index is a well-established 21-item tool for the quantitative assess-
ment of depressive symptoms and is widely used in psychological 
research [32]. It has good psychometric proprieties, with an inter-
nal consistency that is good to excellent (α = 0.83–0.96; [33]) and 
it has been translated and validated in Italian language [34]. Many 
studies have concluded that the BDI is a rational choice of screen-
ing tool for depression in an AUD population [35, 36].
Statistical Analysis
All computations were performed using the IBM SPSS Statis-
tics for MACOS package version 22.0 (IBM Corporation, Armonk, 
NY, USA). 
Gender comparison of baseline data was performed using the 
Pearson’s χ2 test or Fisher’s exact test for categorical variables, de-
pending on the expected frequencies in each group. Mean differ-
ences in continuous variables were evaluated using the indepen-
dent samples t test or the Mann-Whitney U test, depending on 
whether the distribution of variables was normal or non-normal, 
as determined by the Shapiro-Wilk test. 
A generalized linear model for repeated measures was applied 
to analyze gender differences in longitudinal variations of state 
anxiety, trait anxiety, and depression. This model consists of both 
multivariate and univariate analyses of variance. STAI-Y and BDI 
scores at the 4 assessment stages (T0, T1, T2, T3) were used as the 
within-subject variables, and gender was used as the between-sub-
ject factor. The effect sizes of both within- and between-subject 
factors obtained by variance analysis are reported as a partial Eta-
squared (η2p) value. The Huyny-Feldt epsilon correction for de-
grees of freedom was applied when the sphericity assumption was 
not met for the main effects of state anxiety, trait anxiety, depres-
sion, and alcohol use severity. Pairwise comparisons of mean 
scores at different stages of assessment were made by repeated con-
trasts (T0 vs. T1, T1 vs. T2, T2 vs. T3, and T3 vs. T0) and are re-
ported as mean differences with a Sidak-corrected 95% CI. 
Logistic and linear regression analyses were also performed to 
evaluate the predictive value of anxiety and depression for relapse 
and for alcohol use severity respectively. Two logistic regression 
models were carried out for each gender, using relapse (yes/no) at 
T2 and T3 as a dichotomous outcome. Two linear regression mod-
els for each gender were instead applied to relapsed patients only, 
using AUDIT scores as a continuous outcome. Both logistic and 
linear models concerning T2 outcomes were calculated using 
STAY-S, STAY-T, and BDI scores at both T0 and T1 and AUDIT 
scores at T0 as independent variables. All models regarding T3 
outcomes also included STAY-S, STAY-T, BDI, and AUDIT 
scores at T2. Baseline sociodemographic, alcohol intake-related, 
and treatment variables were initially compared by univariate 
analysis. Subsequently, those that were significantly different be-
tween abstinent and relapsed subjects were used as covariates in 
both logistic and linear regression models. Probability tests were 
considered bilateral with a type I error set at 5% (p = 0.05).
Results
The enrolled sample consisted of 187 patients, of 
whom 146 attended both the 6- and 12-month follow-up 
appointments. All patients had a negative admission drug 
urine test and accepted to participate in the study, giving 
written informed consent; thus, no patient was excluded 
from the study.
A total of 41 patients who had agreed to participate in 
the study and had signed informed consent forms, none-
theless, became non-contactable before follow-up: 23 pa-
tients (12.3%) were lost to follow-up before T2 and an 
additional 18 patients (9.6%) lost contact before T3. These 
41 lost patients were thus excluded from the longitudinal 
analysis. However, a comparison between responders 
and lost patients showed no statistically significant differ-
ences in baseline sociodemographic, alcohol intake-relat-
ed, or other variables studied (online suppl. Table 1, see 
www.karger.com/doi/10.1159/000490046). 
Half of our patient population had never undergone de-
toxification, whereas the remainder had been detoxified at 
least once. Taking into account responders only, the com-
parison between genders for age and alcohol intake-related 
variables did not show any differences (Table 1). On aver-
age, both males and females started drinking alcohol at the 
age of 18, began to abuse it 14 years later (age 32), and were 
admitted to a detoxification unit at about age 46. Accord-
ing to baseline AUDIT scores, almost the entire study sam-
ple showed high-risk drinking habits (zone IV), without 
any significant gender differences (Table 1).
The gender comparison of nonpharmacological treat-
ment in responders did not find any statistically signifi-
cant differences (Table 2).
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Outcome of Detoxification
At T2, 78 (47.6%) of the 164 patients remaining in the 
study relapsed to drinking alcohol; they presented scores 
indicating various health risks, and there were no gender 
differences (Fisher’s exact test = 2.90, p = 0.419). According 
to the AUDIT scores, 54 patients (32.9%) had high health 
risk (zone IV, 41 males vs. 13 females), 6 (3.7%) had haz-
ardous drinking (zone III, males vs. 2 females), 12 (7.3%) 
were excessive drinkers (zone II, 7 males vs. 5 females), and 
6 (3.7%) had low health risk (zone 1, 3 males vs. 3 females). 
A total of 86 patients (52.4%) maintained abstinence. 
At T3, 78 (53.4%) of the 146 patients remaining in the 
study relapsed to drinking alcohol, of which 14 (9.6%) 
relapsed between T2 and T3. No gender differences in 
terms of AUDIT zone risk were found (Fisher’s exact test 
= 1.72, p = 0.709): 50 patients (34.2%) had high health risk 
(zone IV, 39 males vs. 11 females), 5 patients (3.4%) had 
hazardous drinking (zone III, 3 males vs. 2 females), 6 
patients (4.1%) had excessive drinking (zone II, 5 males 
vs. 1 female), 17 patients (11.6%) showed a low risk drink-
ing (zone I, 10 males vs. 7 female). A total of 68 patients 
(46.6%) were considered abstinent at T3.
Table 1. Gender comparison of socio-demographic and clinical variables in responders at baseline (n = 146)
Gender χ2(DF) p value
male, n (%) female, n (%)
Education, years
<6
6–8
9–13
>13
7 (7.0)
59 (59.0)
33 (33.0)
1 (1.0)
2 (4.3)
18 (39.1)
21 (45.6)
5 (10.9)
10.61(3)a 0.009*
Marital status
Single
Married/partnered
Separated/divorced
Widowed
37 (37.0)
21 (21.0)
41 (41.0)
1 (1.0)
10 (21.7)
24 (52.2)
11 (23.9)
1 (2.2)
14.73(3)a 0.001*
Living condition
Alone
With partner
With parents
With children
With friends
30 (30.0)
23 (23.0)
40 (40.0)
0 (0.0)
7 (7.0)
10 (21.7)
23 (50.0)
9 (19.6)
4 (8.7)
0 (0.0)
22.19(4)a <0.001*
Employment
Employed
Unemployed
Disability pension
Retired
Housewife
39 (39.0)
43 (43.0)
10 (10.0)
8 (8.0)
0 (0.0)
23 (50.0)
14 (30.4)
0 (0.0)
5 (10.9)
4 (8.7)
15.07(4)a 0.003*
Previous detoxification
0
1
2
>2
57 (57.0)
27 (27.0)
13 (13.0)
3 (3.0)
23 (50.0)
18 (39.1)
4 (8.7)
1 (2.2)
2.31(3)a 0.520
Mean (SD) Mean (SD) U(DF) p value
Age, years 46.9 (8.9) 46.0 (10.8) 0.56(144)b 0.576
Age at onset of alcohol use, years 18.0 (5.7) 18.0 (7.5) 2103.5 0.403
Age at onset of alcohol abuse, years 32.5 (11.4) 32.1 (11.1) 2270.0 0.899
Length of hospitalization 27.5 (6.9) 29.2 (9.0) 2107.5 0.415
a Fisher’s exact test. 
b Students t test with DF.* Statistically significant.
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Longitudinal Analysis of Anxiety, Depression, and 
Alcohol Use
Longitudinal analysis in 146 patients by using the gen-
eralized linear model revealed a significant within-subject 
effect for stages of assessment in state anxiety (F[2.6, 
316.9] = 19.27, p < 0.001, η2p = 0.14), trait anxiety (F[2.8, 
339.1] = 97.12, p < 0.001, η2p = 0.44), and depression 
(F[2.8, 343.3] = 69.17, p < 0.001, η2p = 0.36). The main 
between-subject effect of gender was also significant for 
each of the 3 psychopathological dimensions (state anxi-
ety, F[1, 142] = 11.42, p = 0.001, η2p = 0.086; trait anxiety, 
F[1, 142] = 9.28, p = 0.003, η2p = 0.07; and depression, F[1, 
142] = 15.33, p < 0.001, η2p = 0.11; Table 3).
Gender Differences in Anxiety, Depression, and 
Alcohol Use at Different Stages of Observation
At admission, females showed higher levels of state 
anxiety, trait anxiety, and depression, whereas their alco-
hol use severity did not differ from that of males (Table 3; 
Fig.  1–4). At discharge, levels of state and trait anxiety 
remained significantly higher in females, whereas no gen-
der differences were observed for depression. At first fol-
low-up, only depression levels were significantly higher 
in females than in males, whereas at the 12-month follow-
up, both state anxiety and depression levels were higher 
in females than in males (Table 3).
Gender Differences in Longitudinal Changes in 
Anxiety, Depression, and Alcohol Use
Both genders significantly improved between admis-
sion and discharge in state anxiety, trait anxiety, and de-
pression (Table 4), although females showed a greater im-
provement in depression levels than males (n = 146; 
time × gender T0–T1 contrast, F[1, 142] = 11.43, η2p = 
0.086, p = 0.001). The improvement that was achieved in 
all of the clinical variables during detoxification remained 
significant in both genders within 12 months after dis-
charge (Table 4, T0–T2 and T0–T3 mean differences in 
STAY-S, STAY-T and BDI). Moreover, no significant 
worsening in state anxiety was observed in either gender 
between T1 and T2 and between T2 and T3, whereas in 
males, trait anxiety significantly worsened between T1 
and T2 (Table 4). Depression levels in both genders sig-
nificantly worsened during the 12 months following dis-
charge (Table 4, BDI T1–T3 mean differences), although 
only females had significantly worse symptoms 6 months 
after discharge (Table 4, BDI T1–T2 mean differences).
Regression Analysis
The Sidak-corrected univariate analysis estimation of 
baseline predictors revealed significant differences be-
tween relapsed and abstinent patients at both the T2 and 
T3 follow-ups. Therefore, 4 baseline variables (previous 
detoxifications, χ2[1] = 9.39, p = 0.002; number of previous 
detoxification, U[52] = 184.5, p = 0.001; age of onset of al-
cohol use, U[52] = 153.0, p < 0.001; and age of onset of al-
cohol abuse, U[52] = 172.5, p = 0.002) were used as covari-
ates in the logistic and linear regression models, which 
were used to evaluate the predictive value of anxiety and 
depression for relapse and drinking severity at T2 in female 
patients. Conversely, no baseline variable or nonpharma-
cological treatment was included as a covariate in the lo-
gistic and linear regression models for male patients. The 
logistic and linear models evaluating the predictive value 
of anxiety and depression for relapse and alcohol use sever-
ity at T3 included 3 baseline variables (previous detoxifica-
tions, χ2[1] = 17.76, p < 0.001; number of previous detoxi-
fications, U[110] = 643.0, p < 0.001; and living conditions, 
χ2[4] = 13.12, p = 0.004) for males and no baseline variable 
and no nonpharmacological treatment for females. Re-
garding the prediction of relapse and alcohol use severity 
at T2, only the linear regression model calculated for fe-
males reached statistical significance (adjusted R2 = 0.211, 
F[11, 36] = 2.14, p = 0.042), indicating that predictors and 
covariates had no predictive value for alcohol use severity. 
Conversely, each of the 4 regression models, which were 
used to evaluate the predictive value of anxiety and depres-
sion for relapse and alcohol use severity at T3, reached sta-
Table 2. Gender comparison of non-pharmacological treatment for responders (n = 146)
Gender χ2(DF) p value
male, n (%) female, n (%)
Parent-training intervention, yes 93 (92.8) 44 (93.5) 0.38(1) 0.720
Short-term individual psychotherapy, yes 95 (94.4) 43 (91.9) 0.14(1) 0.707
Group psychotherapy, yes 91 (89.6) 42 (88.7) 0.01(1) 1.000
Motivational enhancement therapy, yes 90 (88.8) 42 (87.0) 0.06(1) 1.000
Nutrition education, yes 90 (88.8) 41 (85.5) 0.03(1) 0.872
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Table 3. Longitudinal variations of state anxiety, trait anxiety and depression (n = 146)
Variable Gender I J Mean differences
(I–J)
95% CI for mean differences p value
inferior limit superior limit
STAY-S M T0 T1 5.177* 1.461 8.893 0.002
T2 4.645* 0.902 8.389 0.007
T3 3.929* 0.368 7.491 0.023
T1 T2 –0.532 –3.493 2.429 0.998
T3 –1.248 –4.350 1.854 0.865
T2 T3 –0.716 –2.903 1.471 0.945
F T0 T1 8.449* 3.011 13.888 <0.001
T2 9.583* 4.104 15.063 <0.001
T3 8.013* 2.800 13.225 <0.001
T1 T2 1.134 –3.200 5.468 0.981
T3 –0.437 –4.977 4.103 1.000
T2 T3 –1.571 –4.772 1.630 0.721
STAY–T M T0 T1 17.412* 13.799 21.025 <0.001
T2 10.764* 6.753 14.774 <0.001
T3 10.634* 6.870 14.398 <0.001
T1 T2 –6.648* –10.025 –3.271 <0.001
T3 –6.777* –10.223 –3.332 <0.001
T2 T3 –0.129 –2.821 2.562 1.000
F T0 T1 19.826* 14.537 25.114 <0.001
T2 17.381* 11.511 23.251 <0.001
T3 17.866* 12.357 23.375 <0.001
T1 T2 –2.444 –7.387 2.498 0.714
T3 –1.960 –7.003 3.084 0.883
T2 T3 0.485 –3.455 4.425 1.000
BDI M T0 T1 9.069* 6.562 11.575 <0.001
T2 6.677* 3.771 9.583 <0.001
T3 6.219* 3.399 9.040 <.001
T1 T2 –2.391 –5.033 0.250 0.097
T3 –2.849* –5.147 –0.552 0.007
T2 T3 –0.458 –2.603 1.687 0.994
F T0 T1 14.687* 11.018 18.356 <0.001
T2 9.553* 5.300 13.806 <0.001
T3 9.841* 5.713 13.969 <0.001
T1 T2 –5.134* –9.000 –1.268 0.003
T3 –4.846* –8.209 –1.483 0.001
T2 T3 0.288 –2.851 3.427 1.000
AUDIT M T0 T1 26.998* 25.026 28.970 <0.001
T2 16.383* 13.554 19.213 <0.001
T3 16.435* 13.072 19.798 <0.001
T1 T2 –10.615* –12.920 –8.309 <0.001
T3 –10.562* –13.328 –7.797 <0.001
T2 T3 0.052 –3.346 3.450 1.000
F T0 T1 28.141* 25.255 31.028 <0.001
T2 17.030* 12.889 21.172 <0.001
T3 19.919* 14.997 24.841 <0.001
T1 T2 –11.111* –14.486 –7.737 <0.001
T3 –8.222* –12.270 –4.175 <0.001
T2 T3 2.889 –2.085 7.863 0.545* Statistically significant.
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tistical significance. According to the logistic models, both 
STAY-S and STAY-T scores at T2 were significant predic-
tors for relapse at T3 in male patients (STAY-S, OR 1.137, 
95% CI 1.012/1.278, p = 0.031; STAY-T, OR 1.096, 95% CI 
1.018/1.179, p = 0.014; Model, Nagelkerke’s R2 = 0.55, 
χ2[10] = 25, p = 0.004), whereas only BDI scores at T2 were 
significant predictors for relapse in female patients (OR 
0.545, 95% CI 0.304/0.978, p = 0.042; Model Nagelkerke’s 
R2 = 0.75, χ2[10] = 30.9, p = 0.001). The linear regression 
models showed that STAY-T scores at T2 had a significant 
predictive value for alcohol use severity in females at T3 
(β = 0.30, t[81] = 2.24, p = 0.27; Model, adjusted R2 = 0.041, 
F[7, 89] = 1.59, p = 0.042), whereas no significant predic-
tors were found for alcohol use severity in males (Model, 
adjusted R2 = 0.340, F[13, 72] = 4.36, p < 0.001).
Discussion
The present study on patients with AUD reveals a 
more severe and different clinical presentation in women 
than in men with regard to anxiety and depression at ad-
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mission to an alcohol detoxification program. Consistent 
with previous studies [9, 15, 19, 20], females with AUD 
suffered from higher levels of state/trait anxiety and de-
pression than males. Although there is strong evidence of 
more severe drinking behaviors in men (for a review see 
Erol & Karpyak, 2015), according to this study, females 
did not differ from males in alcohol use severity at time 
of admission to the inpatient detoxification program. 
This could be explained by the fact that AUDs needing 
hospitalization for detoxification usually show a severe 
pattern of alcohol consumption, regardless of gender. 
The alcohol detoxification program impacted anxiety 
and depression symptoms in both genders, but in con-
trast too previous findings [20], the reduction of depres-
sive symptoms severity was significantly greater in fe-
males than in males. During the 12 months following dis-
charge, levels of anxiety and depression increased without 
reaching those levels encountered at admission, with spe-
cific gender differences; that is, males seemed to present 
state and trait anxiety symptoms more quickly than fe-
males, whereas females were more prone to experiencing 
worsening depressive symptoms. This particular gender 
characterization of psychopathology after detoxification 
has not yet been explicitly recognized by other studies. 
According to the regression analysis performed in this 
study, both state and trait anxiety levels assessed 6 months 
after discharge predicted alcohol relapse in the following 
6 months in males, whereas in females, depression levels 
at the 6-month follow-up predicted relapse 12 months 
after discharge. Therefore, in both genders, the psycho-
pathological dimension showing the most significant ag-
gravation at the 6-month follow-up (i.e., anxiety for males 
and depression for females) was a significant predictor of 
relapse at the 12-month follow-up. The relationship be-
tween negative affect, unpleasant mood states, depres-
sion, and alcohol use, as well as the predictive value of 
depression for alcohol relapse in female with AUD has 
been shown in previous reports [15, 16, 18]. Furthermore, 
other studies have demonstrated that this relationship be-
tween negative affect and relapse among women may be 
mediated by craving [19, 20, 37]. In the present study, the 
extent of relapse appeared to correlate with the recur-
rence of trait anxiety, as the severity of alcohol use behav-
ior was predicted by the level of trait anxiety in relapsed 
females. There has been no evidence in the literature for 
trait or state anxiety being a predictor for alcohol relapse, 
although anxiety disorders have been recognized as con-
ceivable predictors for relapse [14].
Taking into account the findings from our study on 
patients with AUD enrolled in an alcohol detoxification 
program, a gender-tailored approach that provides com-
bined pharmacological and psychosocial intervention fo-
cused on state and trait anxiety for males and on depres-
sion/negative affect for females during the early and late 
post-discharge periods may be useful for reducing both 
individual risk of relapse and overall relapse rate, and for 
Table 4. Gender comparison of state anxiety, trait anxiety, depression and alcohol use severity at different stages of observation (n = 146)
Variables Stage Males Females F(DF) p value η2p
mean 95% CI mean 95% CI
STAY-S T0 39.3 36.6–41.9 47.6 43.6–51.5 11.84(1, 142) 0.001 0.088
T1 34.1 32.1–36.1 39.1 36.1–42.1 7.69(1, 142) 0.006 0.059
T2 34.6 32.4–36.8 38.0 34.7–41.2 2.89(1, 142) 0.092 0.023
T3 35.3 33.2–37.4 39.5 36.4–42.6 4.97(1, 142) 0.028 0.039
STAY-T T0 54.9 52.5–57.2 63.6 60.2–67.1 16.96(1, 142) <0.001 0.122
T1 37.5 35.4–39.5 43.8 40.8–46.8 11.82(1, 142) 0.001 0.088
T2 44.1 41.5–46.7 46.3 42.4–50.1 0.84(1, 142) 0.361 0.007
T3 44.2 41.9–46.5 45.8 42.4–49.1 0.55(1, 142) 0.460 0.004
BDI T0 16.1 14.0–18.3 24.2 21.0–27.3 17.51(1, 142) <0.001 0.126
T1 7.1 5.6–8.5 9.5 7.3–11.7 3.43(1, 142) 0.066 0.027
T2 9.5 7.4–11.5 14.6 11.7–17.6 8.13(1, 142) 0.005 0.062
T3 9.9 8.2–11.6 14.4 11.9–16.8 8.99(1, 142) 0.003 0.069
AUDIT T0 27.0 25.5–28.4 28.1 26.0–30.3 0.76(1, 142) 0.383 0.006
T1 – – – – – – –
T2 10.6 8.9–12.3 11.1 8.6–13.6 0.11(1, 142) 0.746 0.001
T3 10.6 8.5–12.6 8.2 5.2–11.2 1.63(1, 142) 0.204 0.013
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promoting long-term abstinence. A more straightfor-
ward implication of our findings in daily clinical practice 
is that the inclusion of specific assessment tools for de-
pression and anxiety in follow-up examinations could 
help the specialist identify patients at high risk of alcohol 
relapse.
A noteworthy finding, not concerning the aims of the 
study, was that trait anxiety, relatively stable personality 
trait consisting of feeling of apprehension, tension, and 
increased activity of the autonomic nervous system [31], 
significantly decreased during admission in the whole 
sample but progressively increased in the months follow-
ing admission in males only. This unexpected finding is 
partially consistent with that of Driessen et al. [38] who 
have already described changes in trait anxiety during de-
toxification, supporting a not well-recognized relation-
ship between alcohol use/withdrawal and trait anxiety, 
which may involve the autonomic nervous system [39].
The main strengths of this study were the longitudinal 
approach, the evaluation of the predictive value of psy-
chopathological levels for relapse and the long post-dis-
charge observation time. Moreover, the relapse rate ob-
served in our sample was comparable to that reported in 
previous studies [4, 14, 40]. However, the study does have 
some potential limitations. First, although the detoxifica-
tion treatment was fixed and scheduled and all nonphar-
macological treatments were taken into account, we 
 cannot exclude the potential influence of both pharmaco-
logical and nonpharmacological treatments on psycho-
pathological variables, especially during the follow-up 
period when data regarding treatments were lacking. 
 Second, the partial responses at 2 follow-up appoint-
ments (87.7% of 187 enrolled patients at 6 months; 78.1% 
at 12 months) might have led to a nonresponse bias, al-
though no patients actually refused follow-up assess-
ment, and nonresponders were lost patients who could 
no longer be contacted. Third, the time adjustment ap-
plied on AUDIT might affect its psychometric properties, 
but it allowed both a short and long-time follow-up as-
sessments. Fourth, as the assessment of AUD, substance 
use disorders, and psychiatric disorders was made before 
the admission and thus outside the study design, our find-
ings are so far from being considered generalizable. All 
evaluations were performed through self-rating instru-
ments and questionnaires, and even if their psychometric 
proprieties and validity are well assessed, a clinician-ad-
ministered test or interview could have improved the ac-
curacy of the patient’s assessment. Moreover, the collec-
tion of data concerning type and frequency of other ad-
diction habits, especially tobacco smoking, could have 
improved the accuracy of predictors appraisal, reducing 
possible confounding effects.
Further studies are warranted to reach a more compre-
hensive evaluation of gender differences in AUD. A mul-
ticenter design could be considered in order to expand 
our knowledge on this subject. Moreover, these gender 
differences could be evaluated in other addictions, such 
as tobacco smoking or other substance use disorders, and 
in different clinical settings, such as both in outpatients 
and inpatients, taking into account also the effect of psy-
chopharmacological treatments.
Conclusions
The findings of this study confirm the important role 
of gender differences in alcohol detoxification programs, 
with women showing higher levels of anxiety and depres-
sion before and after detoxification. The recurrence of 
anxiety and depressive symptoms in males and females 6 
months after discharge predicted alcohol relapse at the 
12-month follow-up. These findings provide support for 
a gender-tailored approach focusing on the assessment of 
specific symptoms in the early post-detoxification period 
to prevent alcohol relapse and promote long-term absti-
nence.
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